Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy

por Martin, Nikolas T., Crupi, Mathieu J. F., Taha, Zaid, Poutou, Joanna, Whelan, Jack T., Vallati, Sydney, Petryk, Julia, Marius, Ricardo, Austin, Bradley, Azad, Taha, Boulanger, Mason, Burgess, Tamara, Sanders, Ilson, Victoor, Camille, Dickinson, Bryan C., Diallo, Jean-Simon, Ilkow, Carolina S., Bell, John C.
Publicado 2023

Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer

por Crupi, Mathieu J. F., Taha, Zaid, Janssen, Thijs J. A., Petryk, Julia, Boulton, Stephen, Alluqmani, Nouf, Jirovec, Anna, Kassas, Omar, Khan, Sarwat T., Vallati, Sydney, Lee, Emily, Huang, Ben Zhen, Huh, Michael, Pikor, Larissa, He, Xiaohong, Marius, Ricardo, Austin, Bradley, Duong, Jessie, Pelin, Adrian, Neault, Serge, Azad, Taha, Breitbach, Caroline J., Stojdl, David F., Burgess, Michael F., McComb, Scott, Auer, Rebecca, Diallo, Jean-Simon, Ilkow, Carolina S., Bell, John Cameron
Publicado 2022